Achieve Life Sciences News

Keine aktuellen Kursdaten verfügbar
WKN: A2DVFV
ISIN: US0044681049
US-Symbol: ACHV
Typ: Aktie

Warnung
Dieses Wertpapier ist nicht mehr aktuell.

Achieve Life Sciences News

  
11.07.18 Achieve Life Sciences Announces Advancement of Cytisine Development Program Following Meeting with the FDA PR Newswire
26.06.18 Achieve Announces Positive Cytisine Data Demonstrating No Clinically Significant Drug-Drug Interaction PR Newswire
19.06.18 Achieve Life Sciences, Inc. Announces Closing of a $13.8 Million Underwritten Public Offering and Full Exercise of Over-​Allotment Option PR Newswire
15.06.18 Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering PR Newswire
11.06.18 Achieve Announces Publication of Cytisine Data for Next-​Generation Cytisine Molecules PR Newswire
23.05.18 Achieve Life Sciences, Inc. Announces Reverse Stock Split PR Newswire
09.05.18 Achieve Reports Financial Results for First Quarter 2018 PR Newswire
07.05.18 Achieve Announces Patent Granted on Novel Formulation of Cytisine PR Newswire
06.03.18 Achieve Life Sciences Announces Cytisine Symposium at the 17th World Conference on Tobacco or Health PR Newswire
01.03.18 Achieve Announces Recent Highlights and Reports Year-End 2017 Financial Results PR Newswire
20.02.18 Achieve Announces Preliminary Data from Cytisine Phase I/II Multi-​Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study PR Newswire
24.01.18 Achieve Announces Expansion of Partnership with the University of Bristol for Next Generation Cytisine-​Based Therapies to Include Exclusive Rights for Cytisine Development Across Multiple Therapeutic PR Newswire
28.11.17 Achieve Announces Clinical Trial Supply and Cooperation Agreement with the University of Auckland for the Evaluation of Cytisine Compared to Varenicline for Smoking Cessation PR Newswire
14.11.17 Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability of Cytisine in Fed and Fasted Subjects PR Newswire
09.11.17 Achieve Reports Financial Results for Third Quarter 2017 PR Newswire
08.11.17 Achieve to Present at the 29th Annual Piper Jaffray Healthcare Conference on November 28th, 2017 PR Newswire
06.11.17 Achieve Announces Availability of Company Presentation from the Virtual Investor Conference PR Newswire
30.10.17 Live Investor Conference & Webinar: NASDAQ, NYSE and OTC companies present November 2nd PR Newswire
30.10.17 Achieve Announces Company Presentation at Virtual Investor Conference on November 2, 2017 PR Newswire
26.10.17 Achieve Announces Exclusive, Long-term Manufacturing Agreement with Sopharma for Clinical and Commercial Supply of Cytisine PR Newswire
04.10.17 Achieve Announces Advancement of Cytisine Clinical Development Program PR Newswire
14.09.17 Achieve Announces Share Purchase Agreement with Lincoln Park Capital Fund, LLC PR Newswire
16.08.17 Achieve Announces Initiation of Cytisine Clinical Development Program PR Newswire
01.08.17 Achieve Life Sciences Announces Closing of Merger with OncoGenex Pharmaceuticals PR Newswire
13.06.17 Achieve Life Sciences and OncoGenex Pharmaceuticals Announce Form S-4 Registration Statement Declared Effective by SEC PR Newswire
15.05.17 OncoGenex Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2017 PR Newswire
09.05.17 OncoGenex to Report First Quarter 2017 Financial Results on May 15, 2017 PR Newswire
05.05.17 SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Oncogenex Pharmaceuticals, Inc. - OGXI PR Newswire
08.03.17 Achieve Life Sciences and OncoGenex Pharmaceuticals Announce Cytisine Symposium at the Annual Society for Research in Nicotine and Tobacco Conference ("SRNT") PR Newswire
01.03.17 Achieve Life Science and OncoGenex Pharmaceuticals Announce Strategic Collaboration with the National Institutes of Health to Advance the Development of Cytisine for Smoking Cessation PR Newswire
23.02.17 OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Year End 2016 PR Newswire
21.02.17 OncoGenex präsentiert Apatorsen-​Daten: Kommt die Sonderzahlung? sharedeals.de
21.02.17 OncoGenex Pharmaceuticals, Inc. Announces Phase 2 Apatorsen Data for Two Clinical Trials Presented at the American Society of Clinical Oncology (ASCO) 2017 Genitourinary Cancers Symposium PR Newswire
16.02.17 OncoGenex to Report Year End 2016 Financial Results on Feb. 23, 2017 PR Newswire
14.02.17 Nivalis vor Merger: Auch hier ist der Knall sicher! sharedeals.de
10.01.17 OncoGenex kurz vor MEGA-​FUSION! Finanztrends
06.01.17 OncoGenex: Mega-Deal mit Ansage! sharedeals.de
05.01.17 OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. Announce Definitive Merger Agreement PR Newswire
23.12.16 OncoGenex: Wann platzt die Bio-Bombe? sharedeals.de
10.11.16 OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 2016 PR Newswire
03.11.16 OncoGenex to Report Third Quarter 2016 Financial Results on Nov. 10, 2016 PR Newswire
25.10.16 OncoGenex Announces Positive Survival Results from Apatorsen Phase 2 Borealis-2™ Trial in Metastatic Bladder Cancer PR Newswire
13.10.16 OncoGenex Announces Results from the Phase 3 ENSPIRIT Trial of Custirsen in Non-Small Cell Lung Cancer PR Newswire
16.08.16 OncoGenex Announces Results from the Phase 3 AFFINITY Trial of Custirsen in Men with Metastatic Castrate-​Resistant Prostate Cancer PR Newswire
04.08.16 OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Second Quarter 2016 PR Newswire
21.07.16 OncoGenex to Report Second Quarter 2016 Financial Results on August 4, 2016 PR Newswire
12.05.16 OncoGenex Pharmaceuticals, Inc. Reports Financial Results for First Quarter 2016 PR Newswire
28.04.16 OncoGenex to Report First Quarter 2016 Financial Results on May 12, 2016 PR Newswire
26.04.16 Biotech-​Roundup: OncoGenex, Biodel, Paion, Epigenomics sharedeals.de
05.04.16 OncoGenex Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference PR Newswire

Newssuche

  
}